Comprehensive Guide: Management of Acetaminophen Poisoning

Overview and Purpose

This guide summarizes the expert consensus on assessment and treatment of acetaminophen (paracetamol) poisoning, emphasizing: rapid risk stratification, use of the revised Rumack‑Matthew nomogram for acute ingestions, indications and dosing for N‑acetylcysteine (NAC), special scenarios (repeated supratherapeutic ingestion, extended‑release products, coingestions), and criteria for enhanced elimination or transplant consultation.

Core reference: Consensus statement developed by poison center and clinical toxicology experts (JAMA Network Open, 2023).

Initial Assessment and Triage

• Obtain thorough history: age, weight, intent, formulation, dose(s), timing (start and end), duration, ingestion pattern, and coingestants. Consider underlying liver disease or chronic alcohol use.
• Consider history unreliable when time, dose, or pattern is unknown, conflicting, or inconsistent with exam/labs; follow the "unknown/unreliable" pathway if so.
• Perform focused exam: vitals, mental status, repeated vomiting, RUQ tenderness. Document pregnancy test for females of childbearing age.
• Obtain baseline labs as indicated: serum acetaminophen concentration (timing critical), serum electrolytes, CMP, AST/ALT, INR/PT, lactate if altered consciousness/metabolic acidosis, and serum creatinine.

Activated Charcoal (Gastrointestinal Decontamination)

Single‑dose activated charcoal (SDAC) should be considered for acute ingestion of a potentially hepatotoxic amount of acetaminophen if the patient presents early and can protect the airway. Recommended doses: 25–50 g for children and 50–100 g for adults. Do not use if airway unprotected or contraindicated. For extended‑release or suspected prolonged absorption, charcoal may be useful beyond 4 hours if evidence of ongoing absorption exists.

Risk Stratification: Timing and the Revised Nomogram

The Rumack‑Matthew nomogram applies only to acute ingestions where a reliable single exposure time is known and a serum acetaminophen concentration is obtained 4–24 hours after the start of ingestion. The panel revised the nomogram to two actionable lines:

Do not use a concentration obtained before 4 hours to plot on the nomogram. A nondetectable level at 2–4 hours typically excludes significant ingestion but consult a toxicologist if uncertain.

When to Start N‑acetylcysteine (NAC)

• Start NAC if the 4–24 hour acetaminophen concentration plots on or above the treatment (150 µg/mL at 4 h) line.
• If the time of ingestion is unknown/unreliable, or sample drawn >24 hours and clinical toxicity present, start NAC while awaiting tests.
• Start NAC empirically if reported acute dose >200 mg/kg or >10 g and waiting for concentration will delay therapy beyond 8 hours post‑ingestion.

NAC: Dosing Principles and Regimens

The consensus panel recommends selecting a regimen that provides at least 300 mg/kg of NAC in the first 20–24 hours (oral or IV) and initiating treatment as soon as the need is established.

If prior anaphylactoid reaction to NAC occurred, it is not an absolute contraindication for reuse in overdose; manage infusion rate or route and treat reactions as they arise.

Stopping Criteria and Duration of NAC

• Do not stop NAC automatically at 20–21 hours; continue until stopping criteria are met. Stopping criteria include clinical improvement and laboratory evidence of recovery (declining aminotransferases, improving INR, and non‑toxic acetaminophen concentrations) per local protocol and toxicology consultation.
• Patients with ongoing liver injury may require extended NAC beyond initial regimen; reassess labs and clinical course before discontinuation.

Special Scenarios

High‑Risk Ingestion

Defined as acute ingestion of ≥30 g or acetaminophen concentration above the high‑risk nomogram line (300 µg/mL at 4 h). Consider prolonged charcoal for ongoing absorption, heightened monitoring, additional labs for mitochondrial dysfunction (lactate, acid‑base), and consultation for possible increased NAC dosing.

Repeated Supratherapeutic Ingestion (RSTI)

Occurs over >24 hours. Do not use the nomogram. Treat based on presentation: give NAC if acetaminophen concentration >20 µg/mL or AST/ALT abnormal; continue until stopping criteria are met.

Extended‑Release Formulations

Management is similar to immediate‑release products, but charcoal may be beneficial beyond 4 hours if ongoing absorption is suspected (e.g., rising acetaminophen levels). If 4–24 h concentration is above treatment line, treat with NAC; if a 4–12 h level is < treatment line but >10 µg/mL, remeasure in 4–6 hours.

Coingestion With Opioids or Anticholinergics

These agents can delay gastric emptying and acetaminophen absorption. If a 4–24 h concentration is ≤10 µg/mL, another measurement usually not required unless clinical effects suggest delayed absorption. If any level is above the treatment line, give NAC and remeasure as needed.

Children <6 Years

Management mirrors adults. Contact poison center/toxicologist if a single IV acetaminophen dose >90 mg/kg or cumulative >150 mg/kg in 24 hours occurred. Dosing adjustments for NAC formulations may be needed for small children to avoid hyponatremia.

Patients >100 kg

Use same assessment approach; cap NAC dosing calculations at 100 kg for infusion regimens.

Pregnancy

Standard evaluation and NAC management apply. Many clinicians prefer IV NAC in pregnancy although oral NAC is not known to be inferior.

Enhanced Elimination (Extracorporeal) & Indications

• Hemodialysis is recommended in addition to NAC for patients with very high acetaminophen concentrations (example threshold: ≥900 µg/mL) accompanied by acidosis or altered mental status attributed to acetaminophen toxicity.
• If dialysis is performed, increase IV NAC infusion rate to at least 12.5 mg/kg/hr during dialysis; oral NAC does not require dose adjustment for dialysis.

Monitoring, Complications, and When to Consult Transplant

• Monitor serial AST/ALT, INR/PT, bilirubin, creatinine, lactate, electrolytes, and mental status. Track acetaminophen concentrations as clinically indicated.
• Complications: acute liver injury, acute liver failure, coagulopathy, metabolic acidosis, renal failure, encephalopathy, multiorgan failure.
• Consult liver transplant team when progressive AST/ALT rise with worsening coagulation abnormalities, encephalopathy, or multisystem failure despite adequate NAC therapy. Early consultation recommended for persistent deterioration.

Practical Workflow Summary (ED/Poison Center)

1. Rapidly determine if history is reliable; if unreliable, treat as unknown and consider early NAC.
2. If acute single ingestion and reliable time: obtain acetaminophen concentration at 4–24 h and plot on revised nomogram; start NAC if level ≥ treatment line.
3. If presentation <4 h and a potentially toxic dose was taken, consider charcoal and recheck concentration at ≥4 h; consider early NAC if delay will push treatment beyond 8 h post‑ingestion.
4. For RSTI, extended‑release, coingestions, or high‑risk doses, consult poison center/toxicologist for tailored management and potential prolonged NAC or enhanced monitoring.

Key Practical Points

• NAC is safe and relatively inexpensive; when in doubt about timing or dose, start NAC—overtreatment is acceptable compared with missed treatment.
• Do not discontinue NAC purely based on elapsed time; use clinical and laboratory stopping criteria.
• High‑risk ingestions and very high concentrations may warrant dose escalation of NAC and consideration of extracorporeal elimination; consult toxicology or poison center.

Selected References

Rumack-Matthew Nomogram and algorithms:
Primary consensus source for this guide: Management of Acetaminophen Poisoning in the US and Canada: A Consensus Statement, JAMA Network Open (2023).

MD_Calc